Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - TOTAL CURRENT ASSETS
Total Current Assets HALO - Halozyme Therapeutics, Inc.
746 M
LAST VALUE
-10.23%
2 YEAR CAGR
11.77%
5 YEAR CAGR
22.87%
10 YEAR CAGR